Full name
"CALIER POLSKA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.75.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
75.00.Z - Veterinary activities
2019 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,3 | 0,2 | 0,5 | 161,9 |
EBITDA | 1,4 | 0,4 | 0,7 | 84,7 |
Short time liabilities | 0,2 | 0,9 | 1,2 | 26,8 |
Equity capital | 7,3 | 7 | 6,4 | -8 |
Operating profit (EBIT) | 1,3 | 0,2 | 0,5 | 139,2 |
Assets | 7,6 | 8 | 7,6 | -4,9 |
Net profit (loss) | 1 | 0,1 | 0,4 | 166,1 |
Cash | 0 | 1,7 | 1,6 | -9,2 |
Liabilities and provisions for liabilities | 0,2 | 1,1 | 1,2 | 14,5 |
Net income from sale | 13,6 | 10,6 | 10,9 | 3,1 |
Working assets | 6,2 | 6,5 | 6,3 | -3,6 |
Depreciation | 0,1 | 0,2 | 0,2 | 6,3 |
% | % | % | p.p. | |
Profitability of capital | 14 | 2,1 | 6,1 | 4 |
Equity capital to total assets | 96,7 | 86,5 | 83,8 | -2,7 |
Gross profit margin | 9,2 | 1,8 | 4,4 | 2,6 |
EBITDA Margin | 10,2 | 3,5 | 6,2 | 2,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 5 | 32 | 39 | 7 |
Current financial liquidity indicator | 24.87547492980957 | 6.698937892913818 | 5.170622825622559 | -1,5 |
Net dept to EBITDA | -0.03034198097884655 | -4.329540729522705 | -2.224881410598755 | 2,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane